Free Trial
OTCMKTS:GBIM

Globeimmune (GBIM) Stock Price, News & Analysis

Globeimmune logo
$0.0001 0.00 (0.00%)
As of 07/7/2025 11:34 AM Eastern

About Globeimmune Stock (OTCMKTS:GBIM)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0005
Volume
410 shs
Average Volume
410 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GBIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globeimmune and its competitors with MarketBeat's FREE daily newsletter.

GBIM Stock News Headlines

GlobeImmune, Inc. (GBIM) - Yahoo Finance
GlobeImmune, Inc. (GBIM)
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
BSPM Biostar Pharmaceuticals, Inc.
Bubang Co Ltd (014470)
Nihon Knowledge Co Ltd (5252)
See More Headlines

GBIM Stock Analysis - Frequently Asked Questions

Globeimmune's stock was trading at $0.0001 at the beginning of the year. Since then, GBIM shares have increased by 0.0% and is now trading at $0.0001.

Globeimmune, Inc. (OTCMKTS:GBIM) issued its quarterly earnings results on Thursday, May, 12th. The biopharmaceutical company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.12. The biopharmaceutical company had revenue of $0.94 million for the quarter.

Shares of GBIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Globeimmune investors own include Novavax (NVAX), OHR Pharmaceutical (OHRP), Premier Gold Mines (PG), Algonquin Power & Utilities (AQN), Nordic American Tankers (NAT), (BAA) (BAA) and Petroleo Brasileiro S.A.- Petrobras (PBR).

Company Calendar

Last Earnings
5/12/2016
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GBIM
Previous Symbol
NASDAQ:GBIM
CIK
1245104
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-269.17
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:GBIM) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners